For the first time, diabetic spend is flattening faster than non-diabetic spend, a reversal of the previous pattern where diabetes costs outpaced everything else by 2x
Detailed Category Analysis# Receptor Targets# Retatrutide : Triple agonist: GIP, GLP-1, and glucagon receptors simultaneously Tirzepatide : Dual agonist: GIP and GLP-1 receptors Advantage : Retatrutide Weight Loss Efficacy# Retatrutide : Up to 28.7% body weight reduction at 68 weeks (Phase 3 TRIUMPH-4)
Whether youre taking a GLP-1 or not, remember that insulin will always be essential for type 1 diabetes
Do not use expired semaglutide if you decide to switch back
We have the certificates: HACCP/ ISO/ CERES/ FSSC/ HALAL/ KOSHER Our mission: Working for Nutrition
The product should be formulated to minimize exposure to destabilizing agents, such as strong acids or excessive heat